195 related articles for article (PubMed ID: 31015520)
1. The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance.
Ayoub M; Shinde-Jadhav S; Mansure JJ; Alvarez F; Connell T; Seuntjens J; Piccirillo CA; Kassouf W
Sci Rep; 2019 Apr; 9(1):6348. PubMed ID: 31015520
[TBL] [Abstract][Full Text] [Related]
2. The Role of HMGB1 in Radioresistance of Bladder Cancer.
Shrivastava S; Mansure JJ; Almajed W; Cury F; Ferbeyre G; Popovic M; Seuntjens J; Kassouf W
Mol Cancer Ther; 2016 Mar; 15(3):471-9. PubMed ID: 26719575
[TBL] [Abstract][Full Text] [Related]
3. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
4. Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer.
Shinde-Jadhav S; Mansure JJ; Rayes RF; Marcq G; Ayoub M; Skowronski R; Kool R; Bourdeau F; Brimo F; Spicer J; Kassouf W
Nat Commun; 2021 May; 12(1):2776. PubMed ID: 33986291
[TBL] [Abstract][Full Text] [Related]
5. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy.
Ma H; Zheng S; Zhang X; Gong T; Lv X; Fu S; Zhang S; Yin X; Hao J; Shan C; Huang S
Cell Death Dis; 2019 Feb; 10(2):136. PubMed ID: 30755598
[TBL] [Abstract][Full Text] [Related]
6. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
Jiang H; Hu X; Zhang H; Li W
Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
[TBL] [Abstract][Full Text] [Related]
8. Extracellular, but not intracellular HMGB1, facilitates self-DNA induced macrophage activation via promoting DNA accumulation in endosomes and contributes to the pathogenesis of lupus nephritis.
Li X; Yue Y; Zhu Y; Xiong S
Mol Immunol; 2015 May; 65(1):177-88. PubMed ID: 25660970
[TBL] [Abstract][Full Text] [Related]
9. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Oweida AJ; Darragh L; Phan A; Binder D; Bhatia S; Mueller A; Court BV; Milner D; Raben D; Woessner R; Heasley L; Nemenoff R; Clambey E; Karam SD
J Natl Cancer Inst; 2019 Dec; 111(12):1339-1349. PubMed ID: 30863843
[TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
[TBL] [Abstract][Full Text] [Related]
11. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
Kang R; Xie Y; Zhang Q; Hou W; Jiang Q; Zhu S; Liu J; Zeng D; Wang H; Bartlett DL; Billiar TR; Zeh HJ; Lotze MT; Tang D
Cell Res; 2017 Jul; 27(7):916-932. PubMed ID: 28374746
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress.
Wen J; Zhang X
Front Biosci (Landmark Ed); 2023 Oct; 28(10):260. PubMed ID: 37919057
[TBL] [Abstract][Full Text] [Related]
13. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
Front Immunol; 2019; 10():407. PubMed ID: 30930892
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma.
Zhao Y; Yi J; Tao L; Huang G; Chu X; Song H; Chen L
Cell Death Dis; 2018 Apr; 9(4):433. PubMed ID: 29567990
[TBL] [Abstract][Full Text] [Related]
16. The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro.
Huang LF; Yao YM; Li JF; Zhang SW; Li WX; Dong N; Yu Y; Sheng ZY
Fitoterapia; 2012 Dec; 83(8):1514-22. PubMed ID: 22981502
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment.
Chiang Y; Tsai YC; Wang CC; Hsueh FJ; Huang CY; Chung SD; Chen CH; Pu YS; Cheng JC
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):321-333. PubMed ID: 35691449
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the treatment of bladder cancer.
Kaufman DS
Ann Oncol; 2006 May; 17 Suppl 5():v106-12. PubMed ID: 16807436
[TBL] [Abstract][Full Text] [Related]
19. Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation.
Wang L; Yang C; Chu M; Wang ZW; Xue B
Cancer Lett; 2021 Mar; 500():172-181. PubMed ID: 33290869
[TBL] [Abstract][Full Text] [Related]
20. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
